ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,100 | -13.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $59,875 | +27.3% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $47,050 | +18.2% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $39,800 | -2.9% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $41,000 | +17.1% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $35,000 | -42.6% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $61,000 | +5.2% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $58,000 | +38.1% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $42,000 | -31.1% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $61,000 | -6.2% | 2,500 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $65,000 | -51.5% | 2,500 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $134,000 | +30.1% | 2,500 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $103,000 | -14.9% | 2,500 | 0.0% | 0.01% | -37.5% |
| Q2 2020 | $121,000 | +14.2% | 2,500 | 0.0% | 0.01% | -11.1% |
| Q1 2020 | $106,000 | -0.9% | 2,500 | 0.0% | 0.01% | +50.0% |
| Q4 2019 | $107,000 | +18.9% | 2,500 | 0.0% | 0.01% | +50.0% |
| Q3 2019 | $90,000 | +34.3% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $67,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $67,000 | +67.5% | 2,500 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $40,000 | -23.1% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $52,000 | +36.8% | 2,500 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $38,000 | -72.5% | 2,500 | -42.2% | 0.00% | – |
| Q3 2016 | $138,000 | – | 4,329 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |